STAPHYSAGRIA 3 [hp_X]/1

STAPHYSAGRIA · PELLET · Rxhomeo Private Limited d.b.a. Rxhomeo, Inc

No Recall History

Plain English

STAPHYSAGRIA is a pellet containing staphysagria at 3 [hp_X]/1, taken oral. Manufactured by Rxhomeo Private Limited d.b.a. Rxhomeo, Inc.

Key Facts

No Recall History

FDA FAERS database · These are reported events, not confirmed side effects

bunion operation1 reports

foot deformity1 reports

sinus disorder1 reports

synovial cyst1 reports

Source: FDA Drug Label (SPL)For healthcare professionals

USE: Condition listed above or as directed by a physician.

DIRECTIONS: (adults/children) Dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a physician.

WARNINGS: Stop use and ask a physician if symptoms persist for more than 3 days or worsen.

STAPHYSAGRIA contains STAPHYSAGRIA. It is a pellet taken oral. Consult your doctor for specific uses.

STAPHYSAGRIA is not classified as a controlled substance by the DEA.

The generic name for STAPHYSAGRIA is STAPHYSAGRIA. There are 10 other brand versions of STAPHYSAGRIA.

The NDC (National Drug Code) for STAPHYSAGRIA 3 [hp_X]/1 is 15631-0413, listed by Rxhomeo Private Limited d.b.a. Rxhomeo, Inc.

Product NDC

15631-0413

Package NDC

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)